Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Kacey Anderson, PhD

Director
Terns Pharmaceuticals Inc

Kacey Anderson, PhD, is Director of Clinical Pharmacology at Terns Pharmaceuticals. Prior to Terns, Dr. Anderson was a Director of Clinical Pharmacology at EQRx International and prior to that she was at Gilead Sciences in clinical pharmacology. Dr. Anderson has worked on programs from early stage (IND filing and development plan) through approval, including being primary author on multiple m2.7.2’s in both US and ex-US submissions in inflammation and oncology disease areas. She has more than eight years of industry experience which includes designing and leading a variety of Phase 1 studies as well as supporting Phase 2 and Phase 3 studies. Dr. Anderson earned her PhD in Pharmaceutical Sciences from the University of Pittsburgh and holds a Bachelor of Science in Chemistry from St. Lawrence University. She is a Fellow of the American College of Clinical Pharmacology (ACCP) and has served on numerous committees and initiatives within ACCP.

Disclosure information not submitted.

Presentation(s):